ANTIVIRAL COMPOUNDS

The invention provides a new class of compounds exhibiting an inhibitory effect on neuraminidase (NA), hemagglutinin (HA) and structural M2 protein bearing viruses. These compounds are also useful as inhibitors of the replication factors of hepatitis virus type C (HVC). The invention also describes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VERONESI, PAOLO ALBERTO, VERONESI, SUSANNA LUCIA, PESCHECHERA, EMANUELA, RODRIGUEZ, PABLO EDUARDO ANDRES
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides a new class of compounds exhibiting an inhibitory effect on neuraminidase (NA), hemagglutinin (HA) and structural M2 protein bearing viruses. These compounds are also useful as inhibitors of the replication factors of hepatitis virus type C (HVC). The invention also describes pharmaceutical compositions containing the compounds of the invention either alone or in combination admixed with a suitable and pharmaceutically acceptable carrier. L'invention concerne une nouvelle classe de composés présentant un effet inhibiteur sur les virus portant de la neuraminidase (NA), de l'hémagglutinine (HA) et la protéine M2 structurale. Ces composés sont également utiles comme inhibiteurs des facteurs de réplication du virus de l'hépatite de type C (VHC). L'invention décrit également des compositions pharmaceutiques contenant les composés de l'invention, soit individuellement, soit en combinaison en mélange avec un support approprié et pharmaceutiquement acceptable.